Article Image
News Link • Science, Medicine and Technology

Biotech Breakthrough Could Create A $11.4 Trillion Opportunity

• http://www.shtfplan.com

A little-known biotech company is poised to potentially earn millions in revenue with the planned upcoming release of a breakthrough technology that could prevent massive numbers of strokes with a simple test that is affordable and accessible to the average American.

A Multi-Billion-Dollar Problem with a $49,000 Answer

Stroke statistics are shocking: Globally, every year 15 million people suffer a stroke. Of these, some 6 million are killed, while 5 million are rendered permanently disabled. In the U.S. alone, nearly 800,000 people suffer from strokes annually—and someone dies of a stroke every 4 minutes.

Until now, there has been no cost-effective way to screen for Ischemia, the leading indicator of a stroke, which cost the U.S. government alone tens of billions of dollars a year. That could be about to change, thanks to a breakthrough technology from CVR Medical (TSX:CVM.V ; OTC:CRRVF. The company's debut, game-changing medical device has been quietly in development for 10 years, and now it's about to charge out of the gate, hoping to take the market by storm upon FDA market clearance.

What 3D seismic imagery did for super quick discoveries in the oil and gas industry, CVR's  sensory system could do for the medical industry.

CVR's Carotid Stenotic Scan (CSS) is a tool to detect stenosis within the Carotid Arteries, potentially offering patients and caregivers a device for early detection in a quick and repeatable manner. Unlike other comparative modalities, the CSS was designed to function without the assistance of a certified technician.  These three facts combine to create one of the potentially biggest—and most lucrative–phenomena in recent medical equipment market history.

carotid-stenotic-scan

The CSS makes a connection between fluid flow and sub-sonic frequencies to detect arterial disease or blockage. Blood flowing through the carotid arteries produces wave patterns which are shaped and altered by the presence of irregularities on the inner artery walls. CVR's advanced technology captures these wave patterns and analyzes them mathematically with patented algorithms. After a brief test, the analysis is complete, offering a way to potentially identify those at risk of a stroke and arming the healthcare provider with the information necessary to prevent the deadly event. For investors, medical providers, insurers, and the public at large, the secondary benefit is that this new innovation has a price tag that renders testing up to 50 times cheaper than many tools on the market today.

Join us on our Social Networks:

 

Share this page with your friends on your favorite social network:


GoldMoney